Our results strongly argue for that despite the fact that both CCL22 and TGF-β1 involve in the tumor infiltration of Tregs, only CCL22 expression can serve as an independent prognostic predictor of BC patient’s survival. This evidence concerns the gene CCL22 and neoplasm.